載入...
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
The lengthy duration of multidrug therapy needed to cure tuberculosis (TB) poses significant challenges for global control of the disease. Moreover, chronic inflammation associated with TB leads to pulmonary damage that can remain even after successful cure. Thus, there is a great need for the devel...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911353/ https://ncbi.nlm.nih.gov/pubmed/27379099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00238 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|